Drug recall · February 19, 2020
Caduet (amlodipine besylate/atorvastatin calcium) Tablets recall
Why: Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/10 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2160-30.
- Lots / codes
Lot #: CY0963, Exp 07/2022
- Quantity
- 128 bottles
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide in the USA.
- Initiated
- February 5, 2020 · Voluntary: Firm initiated
- Classified
- February 13, 2020
- Reported
- February 19, 2020
- Ended
- March 8, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atorvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.